{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:13:42Z","timestamp":1790871222285,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.nucmedbio.2007.01.004","type":"journal-article","created":{"date-parts":[[2007,3,24]],"date-time":"2007-03-24T11:06:19Z","timestamp":1174734379000},"page":"293-304","source":"Crossref","is-referenced-by-count":28,"title":["In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Emmanuelle N.","family":"Sabbah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Kadouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Finucane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Decaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nucmedbio.2007.01.004_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.nucmedbio.2007.01.004_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.gassur.2005.10.018","article-title":"Adjuvant treatment strategies for pancreatic cancer","volume":"10","author":"Newman","year":"2006","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.nucmedbio.2007.01.004_bib3","first-page":"485","article-title":"Pancreatic cancer: diagnosis and management","volume":"73","author":"Freelove","year":"2006","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.nucmedbio.2007.01.004_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.critrevonc.2006.02.004","article-title":"Current therapies and advances in the treatment of pancreatic cancer","volume":"58","author":"Mancuso","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1016\/j.nucmedbio.2007.01.004_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/11024159950189717","article-title":"Efficacy of monoclonal antibody 131I-B72.3 immunoscintigraphy of pancreatic adenocarcinoma xenografts in nude mice","volume":"165","author":"Kaufmann","year":"1999","journal-title":"Eur J Surg"},{"issue":"3","key":"10.1016\/j.nucmedbio.2007.01.004_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.10311","article-title":"Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma","volume":"84","author":"Otsuji","year":"2003","journal-title":"J Surg Oncol"},{"issue":"22","key":"10.1016\/j.nucmedbio.2007.01.004_bib7","first-page":"7246","article-title":"Radiolocalization of human pancreatic tumors in athymic mice by monoclonal antibody DU-PAN 1","volume":"50","author":"Worlock","year":"1990","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.nucmedbio.2007.01.004_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00006676-199305000-00002","article-title":"Radioimmunoimaging of xenograft pancreatic cancer with 131I-monoclonal antibody P2","volume":"8","author":"Yao","year":"1993","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.nucmedbio.2007.01.004_bib9","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1158\/1078-0432.CCR-03-0340","article-title":"Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy","volume":"10","author":"Cardillo","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.nucmedbio.2007.01.004_bib10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ijc.20004","article-title":"Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft","volume":"109","author":"Gold","year":"2004","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.nucmedbio.2007.01.004_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1593\/neo.04298","article-title":"Monoclonal antibody 16D10 to the C-terminal domain of the feto-acinar pancreatic protein binds to membrane of human pancreatic tumoral SOJ-6 cells and inhibits the growth of tumor xenografts","volume":"6","author":"Panicot-Dubois","year":"2004","journal-title":"Neoplasia"},{"issue":"7 Pt 1","key":"10.1016\/j.nucmedbio.2007.01.004_bib12","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1158\/1078-0432.CCR-05-1682","article-title":"Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy","volume":"12","author":"Tonra","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.nucmedbio.2007.01.004_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02785919","article-title":"Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers","volume":"21","author":"Friess","year":"1997","journal-title":"Int J Pancreatol"},{"issue":"10","key":"10.1016\/j.nucmedbio.2007.01.004_bib14","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/sj.bjc.6601362","article-title":"Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer","volume":"89","author":"Azria","year":"2003","journal-title":"Br J Cancer"},{"issue":"2\u20133","key":"10.1016\/j.nucmedbio.2007.01.004_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3835(92)90132-F","article-title":"Cytosol and serum ferritin in breast carcinoma","volume":"67","author":"Guner","year":"1992","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.nucmedbio.2007.01.004_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF01806307","article-title":"Tissue ferritin concentration and prognosis in carcinoma of the breast","volume":"14","author":"Weinstein","year":"1989","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.nucmedbio.2007.01.004_bib17","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1073\/pnas.71.10.3956","article-title":"Ferritin, a Hodgkin's disease associated antigen","volume":"71","author":"Eshhar","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.nucmedbio.2007.01.004_bib18","first-page":"71","article-title":"Human isoferritins in normal and disease states","volume":"14","author":"Drysdale","year":"1977","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2007.01.004_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0003-9861(74)90209-4","article-title":"Isolation of ferritin from human mammary and pancreatic carcinomas by means of antibody immunoadsorbents","volume":"162","author":"Marcus","year":"1974","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"10.1016\/j.nucmedbio.2007.01.004_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/cbr.2000.15.431","article-title":"Radiolabeled immunoglobulin therapy in patients with Hodgkin's disease","volume":"15","author":"Vriesendorp","year":"2000","journal-title":"Cancer Biother Radiopharm"},{"issue":"23 Suppl","key":"10.1016\/j.nucmedbio.2007.01.004_bib21","first-page":"5888s","article-title":"Review of five consecutive studies of radiolabeled immunoglobulin therapy in Hodgkin's disease","volume":"55","author":"Vriesendorp","year":"1995","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.nucmedbio.2007.01.004_bib22","first-page":"6383","article-title":"Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma","volume":"49","author":"Klein","year":"1989","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.nucmedbio.2007.01.004_bib23","first-page":"443","article-title":"Analysis of various isoferritins with monoclonal antibodies","volume":"295","author":"Kadouche","year":"1982","journal-title":"C R Seances Acad Sci III"},{"key":"10.1016\/j.nucmedbio.2007.01.004_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nprot.2006.49","article-title":"Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes","volume":"1","author":"Cooper","year":"2006","journal-title":"Nature Protocols"},{"issue":"1","key":"10.1016\/j.nucmedbio.2007.01.004_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0003-2697(84)90517-7","article-title":"Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions","volume":"142","author":"Meares","year":"1984","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.nucmedbio.2007.01.004_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-1759(84)90435-6","article-title":"Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess","volume":"72","author":"Lindmo","year":"1984","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.nucmedbio.2007.01.004_bib27","first-page":"250","article-title":"Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics","volume":"106","author":"Kyriazis","year":"1982","journal-title":"Am J Pathol"},{"issue":"2\u20133","key":"10.1016\/j.nucmedbio.2007.01.004_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2005.08.021","article-title":"The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates","volume":"108","author":"Goldstein","year":"2005","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.nucmedbio.2007.01.004_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10555-005-6195-z","article-title":"Antibody-guided radiation therapy of cancer","volume":"24","author":"Koppe","year":"2005","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"10.1016\/j.nucmedbio.2007.01.004_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0883-2897(91)90107-V","article-title":"The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates","volume":"18","author":"Harrison","year":"1991","journal-title":"Int J Rad Appl Instrum B"},{"issue":"5","key":"10.1016\/j.nucmedbio.2007.01.004_bib31","first-page":"672","article-title":"Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts","volume":"30","author":"Roselli","year":"1989","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.nucmedbio.2007.01.004_bib32","first-page":"882","article-title":"Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies","volume":"35","author":"Camera","year":"1994","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.nucmedbio.2007.01.004_bib33","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0968-0896(97)00130-2","article-title":"Stereochemical influence on the stability of radio-metal complexes in vivo. Synthesis and evaluation of the four stereoisomers of 2-(p-nitrobenzyl)-trans-CyDTPA","volume":"5","author":"Wu","year":"1997","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"10.1016\/j.nucmedbio.2007.01.004_bib34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nbt1141","article-title":"Arming antibodies: prospects and challenges for immunoconjugates","volume":"23","author":"Wu","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10.1016\/j.nucmedbio.2007.01.004_bib35","first-page":"3186","article-title":"Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer","volume":"7","author":"Cardillo","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.nucmedbio.2007.01.004_bib36","first-page":"1183","article-title":"Hematologic side effects of radiolabeled immunoglobulin therapy","volume":"24","author":"Vriesendorp","year":"1996","journal-title":"Exp Hematol"},{"key":"10.1016\/j.nucmedbio.2007.01.004_bib37","first-page":"3929S","article-title":"Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer","volume":"9","author":"Gold","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.nucmedbio.2007.01.004_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bpg.2005.11.009","article-title":"What's new in pancreatic cancer treatment pipeline?","volume":"20","author":"Von Hoff","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"Suppl 5","key":"10.1016\/j.nucmedbio.2007.01.004_bib39","doi-asserted-by":"crossref","first-page":"v148","DOI":"10.1093\/annonc\/mdj971","article-title":"New target therapies in advanced pancreatic cancer","volume":"17","author":"Cascinu","year":"2006","journal-title":"Ann Oncol"},{"issue":"1\u20132","key":"10.1016\/j.nucmedbio.2007.01.004_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2006.02.002","article-title":"Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?","volume":"9","author":"Kleespies","year":"2006","journal-title":"Drug Resist Updat"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980510700011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980510700011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T19:27:17Z","timestamp":1628710037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096980510700011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S096980510700011X"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2007.01.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}